Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02302963 · ClinicalTrials.gov registry record · NA
USS Virginia Closed-Loop Versus SAP Therapy for Hypoglycemia Reduction in T1D
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT02302963 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 85 participants.
The verdict
NCT02302963, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
This is a randomized, controlled trial of Unified Safety System (USS) Virginia closed-loop versus sensor-augmented pump (SAP) therapy for hypoglycemia prevention in subjects with type 1 diabetes and hypoglycemia unawareness and/or risk for hypoglycemia.
Interventions
- DEVICE AP System (DiAs or inControl) with USS Virginia
- DEVICE Sensor-Augmented Pump Therapy (placebo)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02302963
The ClinicalTrials.gov registry entry for NCT02302963 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AP System (DiAs or inControl) with USS Virginia is the first listed.
NCT02302963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02302963 about?
NCT02302963 is a clinical study titled "USS Virginia Closed-Loop Versus SAP Therapy for Hypoglycemia Reduction in T1D". This is a randomized, controlled trial of Unified Safety System (USS) Virginia closed-loop versus sensor-augmented pump (SAP) therapy for hypoglycemia prevention in subjects with type 1 diabetes and hypoglycemia unawareness and/or risk for hypoglycemia.
What is the current status of trial NCT02302963?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2015-06. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02302963?
The interventions under investigation include: AP System (DiAs or inControl) with USS Virginia (DEVICE), Sensor-Augmented Pump Therapy (placebo) (DEVICE).
Who is sponsoring clinical trial NCT02302963?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.